Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.86 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.86 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.86 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | DGKA | P23743 | 1/20 | 0.68 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.66 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.66 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | SELP | P16109 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL637876 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| Glyceryl Trioleate SCHEMBL11046635 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12677747 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21443903 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL25386238 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21641598 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL25386239 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21641597 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL23225841 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21439775 | 1.00 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110087624-B | Skin temperature sensitive lipid composition and cosmetic composition | CJ第一制糖株式会社 | 2023-02-17 | — | — | CN | claimed |
| EP-3517096-A1 | SKIN TEMPERATURE-SENSITIVE FAT COMPOSITION AND A COSMETIC COMPOSITION | CJ Cheiljedang Corporation (KR) | 2019-07-31 | — | — | EP | claimed |
| US-9193962-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them | DSM IP ASSETS B.V. (NL) | 2015-11-24 | — | — | US | claimed |
| EP-2329032-B1 | Methods using polypeptides having hydrolase activity | BUNGE OILS INC (US) | 2014-04-30 | — | — | EP | claimed |
| US-8465942-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them | BUNGE OILS, INC. (US) | 2013-06-18 | — | — | US | claimed |
| US-8349578-B2 | Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids | BUNGE OILS, INC. (US) | 2013-01-08 | — | — | US | claimed |
| US-20120258505-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | BUNGE OILS, INC. | 2012-10-11 | — | — | US | claimed |
| US-20120227120-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | DSM IP ASSETS B.V. (NL) | 2012-09-06 | — | — | US | claimed |
| US-8227215-B2 | Hydrolases, nucleic acids encoding them and methods for making and using them for biocatalytic synthesis of a structured lipid | BUNGE OILS, INC. (US) | 2012-07-24 | — | — | US | claimed |
| JP-4829105-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| WO-2007055735-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION (US) | 2007-05-18 | — | — | WO | claimed |
| WO-2006096834-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR IMPROVING PAPER STRENGTH | DIVERSA CORPORATION (US) | 2006-09-14 | — | — | WO | claimed |
| EP-1601332-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND MEHODS FOR MAKING AND USING THEM | DIVERSA CORPORATION (US) | 2005-12-07 | — | — | EP | claimed |
| WO-2005032496-A2 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND MEHODS FOR MAKING AND USING THEM | DIVERSA CORPORATION (US) | 2005-04-14 | — | — | WO | claimed |
| EP-0196210-B2 | Cacao butter substitute composition | KAO CORP (JP) | 1999-01-20 | — | — | EP | claimed |
| EP-0237307-B1 | SUBSTITUTE COMPOSITION FOR COCOA BUTTER | Kao Corporation (JP) | 1992-04-22 | — | — | EP | claimed |
| EP-0196210-B1 | CACAO BUTTER SUBSTITUTE COMPOSITION | Kao Corporation (JP) | 1990-05-30 | — | — | EP | claimed |
| US-4873109-A | Cacao buttern substitute composition | KAO CORPORATION (JP) | 1989-10-10 | — | — | US | claimed |
| US-4705692-A | MIXED TRIGLYCERIDES | KAO CORPORATION (JP) | 1987-11-10 | — | — | US | claimed |
| EP-0196210-A2 | Cacao butter substitute composition | Kao Corporation (JP) | 1986-10-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120227120-A1 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | PNLIP, NOTUM, LIPC | PRKCA 1637/4885PRKCE 1943/4885PRKCQ 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.